In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...
Hello, and welcome to the eXp World Holdings fourth quarter and full year 2024 earnings fireside chat via live stre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback